Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACXP is expected to report earnings to fall 8.06% to -56 cents per share on August 17

Acurx Pharmaceuticals ACXP Stock Earnings Reports

Q2'26

Est.

$-0.57

Q1'26

Missed

by $0.48

Q4'25

Missed

by $0.60

Q3'25

Missed

by $1.08

Q2'25

Missed

by $1.71

The last earnings report on May 12 showed earnings per share of -62 cents, missing the estimate of -14 cents. With 35.82K shares outstanding, the current market capitalization sits at 6.50M.

View a ticker or compare two or three

Compare

ACXP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ACXP